Yuta Ushida

High CA19-9 level in resectable pancreatic cancer is a potential indication of neoadjuvant treatment

Yuta Ushida, Yosuke Inoue, Hiromichi Ito et al. · Pancreatology · 2020 · 50 citations

Surgical Oncology, Pancreatic Cancer, High Ca19-9 Level +11

Optimizing Indications for Conversion Surgery Based on Analysis of 454 Consecutive Japanese Cases with Unresectable Pancreatic Cancer Who Received Modified FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel: A Single-Center Retrospective Study

Yuta Ushida, Yosuke Inoue, Atsushi Oba et al. · Annals of Surgical Oncology · 2022 · 45 citations

Surgical Oncology, Pancreatic Cancer, Gastrointestinal Oncology +10

Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy

Thomas F. Stoop, Atsushi Oba, Yan‐Dong Wu et al. · JAMA Network Open · 2024 · 24 citations · Full text

Impact of Tumor Size on the Outcomes of Patients with Resectable Distal Pancreatic Cancer: Lessons Learned from a Series of 158 Radical Resections

Genki Watanabe, Yuta Ushida, Atsushi Oba et al. · Annals of Surgical Oncology · 2021 · 13 citations

Radical Resections, Surgical Oncology, Pancreatic Cancer +8

Comparison of the outcomes between total eversion and conventional triangulating stapling technique in cervical esophagogastric anastomosis after esophagectomy: a propensity score-matched analysis

Keita Takahashi, Masayuki Watanabe, Yuta Ushida et al. · Esophagus · 2021 · 10 citations